PROJECT SUMMARY:
Cold temperature (<15°C) exposure stimulates perivascular beige adipocyte progenitor cells (bAPCs) to
generate beige adipocytes. Beige adipocytes act as cellular furnaces to burn blood glucose and free fatty acids
to generate heat. Recent studies have shown the metabolic benefits of beige adipocytes, suggesting potential
clinical efficacy for obese patients and type 2 diabetics. However, the potential to form cold-induced beige
adipocytes declines with age, creating a pivotal challenge to the therapeutic promise for older individuals, many
of whom constitute the obesity epidemic. Our studies begin to unravel how aging suppresses beige adipogenic
potential and identifies new ways to rejuvenate beige fat cell biogenesis to restore metabolic fitness in aged
mammals. Our previous studies have linked cellular senescence, a state of cellular arrest, of bAPCs to the age-
associated decline in beige adipose tissue. In an attempt to find additional mechanisms blocking beige fat
biogenesis in aged mammals, we found that the expression and signaling of platelet derived growth factor
receptor beta (Pdgfrβ) is increased in aged bAPCs. Moreover, ablation of Pdgfrβ within the beige adipose lineage
restored beige adipocyte generation and improved metabolic health in aged (not young) mice. Despite beige fat
formation in aged Pdgfrβ-deficient mice, lineage-tracing studies revealed that auxiliary source(s) generated
beige adipocytes. In agreement, senescence tests demonstrated that Pdgfrβ neither promoted nor reversed
cellular senescence. Instead, we found that Pdgfrβ signaling prevents group 2 innate lymphoid cell (ILC2)
recruitment and activation within iWAT depots. Mechanistically, we identified that Pdgfrβ elicits signals via Stat1
to suppress the ILC2-inducer, interleukin-33 (IL-33), to control WAT ILC2 activity. Finally, we identify sympathetic
tone as a significant regulator of age-induced Pdgfrβ expression. Our aims will elucidate the physiological and
cellular role of Pdgfrβ in regulating beige fat biogenesis under aging and obese conditions. We will elucidate the
Pdgfrβ-Stat1 signaling mechanism in bAPCs to control ILC2 recruitment via IL-33. We uncover how sympathetic
output regulates Pdgfrβ expression to drive the age-dependent beige adipogenic failure. These findings will
implicate Pdgfrβ signaling as a central node in the bAPC aging process. Importantly, this application will identify
factors that reverse age-dependent beige adipogenic failure with a direct clinical utility to combat excess body
fat and metabolic dysfunction to extend lifespan and restore health.
Public Health Relevance Statement
PROJECT NARRATIVE:
Mammalian aging is associated with the expansion and accumulation of fat tissue which hinders metabolic
function and increases the incidence of premature death due to type 2 diabetes and cardiovascular disease.
Cold temperatures can stimulate progenitor cells to form thermogenic beige fat which can boost metabolism to
counteract uncontrolled fat accumulation and metabolic disease; however, the potential to create beige fat cells
declines with age. Our application seeks to decipher how aging disrupts beige fat development with the goal to
revive beige fat to promote healthy fat tissue and fuel metabolic fitness in aging humans.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
15-March-2022
Project End Date
31-January-2027
Budget Start Date
01-February-2025
Budget End Date
31-January-2026
Project Funding Information for 2025
Total Funding
$432,536
Direct Costs
$279,648
Indirect Costs
$152,888
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Diabetes and Digestive and Kidney Diseases
$432,536
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK132264-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK132264-04
Patents
No Patents information available for 5R01DK132264-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK132264-04
Clinical Studies
No Clinical Studies information available for 5R01DK132264-04
News and More
Related News Releases
No news release information available for 5R01DK132264-04
History
No Historical information available for 5R01DK132264-04
Similar Projects
No Similar Projects information available for 5R01DK132264-04